Bristol-Myers to invest in Compugen, collaborate in clinical trials
Monday, October 15, 2018 - 01:23
in Health & Medicine
Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors.